IRIS
AGUSTONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.309
AS - Asia 1.303
EU - Europa 839
SA - Sud America 218
AF - Africa 83
OC - Oceania 1
Totale 3.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.238
SG - Singapore 420
CN - Cina 337
HK - Hong Kong 207
RU - Federazione Russa 178
IT - Italia 170
VN - Vietnam 165
BR - Brasile 151
DE - Germania 119
FR - Francia 80
FI - Finlandia 73
GB - Regno Unito 65
ZA - Sudafrica 57
IN - India 46
IE - Irlanda 38
CA - Canada 37
BD - Bangladesh 27
MX - Messico 23
NL - Olanda 22
AR - Argentina 21
PL - Polonia 20
JP - Giappone 15
IQ - Iraq 14
TR - Turchia 14
AT - Austria 13
ES - Italia 13
VE - Venezuela 13
CZ - Repubblica Ceca 10
SE - Svezia 10
SA - Arabia Saudita 8
CO - Colombia 7
EC - Ecuador 7
MA - Marocco 7
UA - Ucraina 7
PH - Filippine 6
PK - Pakistan 6
BE - Belgio 5
CL - Cile 5
PY - Paraguay 5
DZ - Algeria 4
ID - Indonesia 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
MY - Malesia 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
LV - Lettonia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
ET - Etiopia 2
JM - Giamaica 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
RW - Ruanda 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
YE - Yemen 1
Totale 3.753
Salva come PNG Salva come JPEG
Città #
Singapore 229
Hong Kong 206
San Jose 193
Ashburn 179
Dallas 176
Beijing 99
Boardman 59
Lauterbourg 58
Los Angeles 52
Munich 52
Ho Chi Minh City 50
Johannesburg 47
Hanoi 45
New York 45
Shanghai 40
Dublin 37
Redondo Beach 37
Turku 37
Helsinki 36
Moscow 36
Milan 32
Pavia 19
São Paulo 19
Warsaw 18
Falkenstein 16
Frankfurt am Main 16
London 15
Tokyo 15
Buffalo 14
Düsseldorf 14
Santa Clara 14
Chennai 13
Montreal 13
Orem 12
The Dalles 12
Toronto 12
Rome 11
Seattle 11
Brooklyn 10
Guangzhou 10
Phoenix 10
Stockholm 10
Boston 9
Manchester 9
Mexico City 9
Nuremberg 9
Chicago 8
Columbus 8
Atlanta 7
Baghdad 7
Brno 7
Cesena 7
Da Nang 7
Dhaka 7
Hyderabad 7
Palermo 7
Amsterdam 6
Bắc Ninh 6
Elk Grove Village 6
Hải Dương 6
Querétaro 6
Ankara 5
Denver 5
Fortaleza 5
Haiphong 5
Houston 5
Poplar 5
Rio de Janeiro 5
Vancouver 5
Vienna 5
Amman 4
Bishkek 4
Bondo 4
Changsha 4
Nairobi 4
San Francisco 4
Tianjin 4
Washington 4
Agadir 3
Asunción 3
Belo Horizonte 3
Buenos Aires 3
Charlotte 3
Desio 3
Durban 3
Florence 3
Istanbul 3
Jacksonville 3
Jeddah 3
Joinville 3
Ludhiana 3
Maastricht 3
Maracaibo 3
Mumbai 3
New Delhi 3
Quito 3
Riga 3
'Asir Region 2
Addis Ababa 2
Bagnaria 2
Totale 2.307
Salva come PNG Salva come JPEG
Nome #
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 143
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 119
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 113
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 98
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 97
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 96
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 95
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 95
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 90
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets 90
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 89
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 89
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study 87
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 87
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective 86
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 84
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design 72
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 71
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer 70
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry 66
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 66
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC 65
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study 64
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study 63
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling 63
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? 62
Radiomics features as predictive and prognostic biomarkers in NSCLC 61
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease 60
Impact of hyponatremia in a tertiary cancer center: a one-year-survey at National Cancer Institute of Milan 57
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 56
EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis 56
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 56
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review 55
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions 54
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 53
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer 53
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 52
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma 52
Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features 51
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines 50
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group 50
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 50
The Clinical Value of Nutritional Care before and during Active Cancer Treatment 48
T-Cell Activation and Maturation at Tumor Site Associated With Objective Response to Ipilimumab in Metastatic Melanoma 47
A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination 47
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer 43
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 43
Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact 41
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 41
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients 40
Is a Dexamethasone-Sparing Strategy Capable of Preventing Acute and Delayed Emesis Caused by Combined Doxorubicin and Paclitaxel for Breast Cancer? Analysis of a Phase II Trial 36
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy 34
PACIFIC trial: new perspectives for immunotherapy in lung cancer 32
Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story 31
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy 31
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations 30
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy? 28
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy 27
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studies 27
Palonosetron Plus 1-Day Dexamethasone for the Prevention of Nausea and Vomiting Due to Moderately Emetogenic Chemotherapy: Effect of Established Risk Factors on Treatment Outcome in a Phase III Trial 27
Palonosetron Plus Dexamethasone in Highly Emetogenic Chemotherapy: Pooled Data from Two Phase III Trials 25
Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders 22
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy 21
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem 20
Totale 3.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023137 0 0 0 0 8 0 1 3 31 0 79 15
2023/2024343 40 46 29 27 31 69 31 15 0 18 6 31
2024/20251.096 40 45 33 22 11 123 54 62 260 84 121 241
2025/20262.251 203 149 241 315 310 103 377 137 264 152 0 0
Totale 3.827